Soret, M., Bacharach, S
Disclosures: Philip Hemken: Nothing to Disclose, Lori Sokoll: Nothing to Disclose, Laurel Jackson: Abbott Laboratories: Employee, Susan Gawel: Nothing to Disclose, Toru Yoshimura: Abbott Japan: Employee, Abbott Laboratories: Stock - publicly traded company, Hideki Kinukawa: Nothing to Disclose, Shaohua Ning: Nothing to Disclose, Juru Miao: Nothing to Disclose, Daniel Chan: Nothing to Disclose, Gerard Davis: Nothing to Disclose 1986 XCT + MONOCYTE-DERIVED MACROPHAGES MEDIATE LIVER FIBROSIS RESOLUTION THROUGH EFFEROCYTOSIS Kyurae Kim 1 Sung Eun Choi 1 Min Jeong Kim 1 Katherine Po Sin Chung 1 Eunmi Lee 1 Kwang Woo Lee 1 WON-IL JEONG 1 , 1 GSMSE, KAIST Background: Hepatic macrophages are key regulators of liver fibrosis progression and regression
The National Sanitation Foundation (NSF) grants its seal of approval when it determines that a product, its manufacturing process, and the manufacturing facility comply with its internal requirements
Similar to protein SH groups, protein methionine residues undergo oxidation to methionine sulfoxide (MetO) in efforts to protect critical residues at the active protein site from oxidative modification and inactivation (80, 201)
